Efficacy and safety of dihydroartemisinin-piperaquine

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 101, Issue 9, 2007, Pages 858-866

  Myint, H Y ^a   Ashley, E A ^b   Day, N P J ^a,c   Nosten, F ^a,c,d   White, N J ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b EPICENTRE   (France)

^c CHURCHILL HOSPITAL   (United Kingdom)

^d SHOKLO MALARIA RESEARCH UNIT   (Thailand)

Author keywords

Antimalarials; Dihydroartemisinin piperaquine; Efficacy; Falciparum malaria; Multidrug resistance; Southeast Asia

Indexed keywords

AMODIAQUINE; ANTIMALARIAL AGENT; ARTECOM; ARTESUNATE; ATOVAQUONE PLUS PROGUANIL; DIHYDROARTEMISININ; FANSIDAR; MEFLOQUINE; PIPERAQUINE; PRIMAQUINE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ABDOMINAL PAIN; ANOREXIA; BLOOD CELL COUNT; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; DIARRHEA; DIZZINESS; DRUG COST; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; GLUCOSE BLOOD LEVEL; HEADACHE; HEMATOCRIT; HEMATOLOGIC DISEASE; HUMAN; LEUKOCYTE COUNT; LIVER DYSFUNCTION; MALARIA; MALARIA FALCIPARUM; MENTAL DISEASE; MULTIDRUG RESISTANCE; NAUSEA; NEUROLOGIC DISEASE; PLASMODIUM VIVAX; PROSPECTIVE STUDY; QT PROLONGATION; REVIEW; SIDE EFFECT; SKIN DISEASE; SLEEP DISORDER; SOUTHEAST ASIA; TREATMENT DURATION; VOMITING;

ANTIMALARIALS; ARTEMISININS; ASIA, SOUTHEASTERN; DRUG COMBINATIONS; FEMALE; HUMANS; MALARIA, FALCIPARUM; MALE; QUINOLINES; SESQUITERPENES; TREATMENT OUTCOME;

EID: 34447617873     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2007.05.018     Document Type: Review

References (38)

1. Abacassamo F., Enosse S., Aponte J.J., Gomez-Olive F.X., Quinto L., Mabunda S., Barreto A., Magnussen P., Ronn A.M., Thompson R., and Alonso P.L. Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria. Trop. Med. Int. Health 9 (2004) 200-208
2. Ashley E.A., Krudsood S., Phaiphun L., Srivilairit S., McGready R., Leowattana W., Hutagalung R., Wilairatana P., Brockman A., Looareesuwan S., Nosten F., and White N.J. Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand. J. Infect. Dis. 190 (2004) 1773-1782
3. Ashley E.A., McGready R., Hutagalung R., Phaiphun L., Slight T., Proux S., Thwai K.L., Barends M., Looareesuwan S., White N.J., and Nosten F. A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria. Clin. Infect. Dis. 41 (2005) 425-432
4. Barnes K.I., Durrheim D.N., Little F., Jackson A., Mehta U., Allen E., Dlamini S.S., Tsoka J., Bredenkamp B., Mthembu D.J., White N.J., and Sharp B.L. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. PloS Med. 2 (2005) e330
5. Changxiong L., Lin X., Huang Z.S., Chen Y.S., and Guo R.N. In vivo sensitivity of Plasmodium falciparum to piperaquine phosphate assayed in Linshui and Baisha counties, Hainan Province. Chin. J. Parasitol. Parasitic Dis. 7 (1989) 163-165
6. Chen L., Qu F.-Y., and Zhou Y.-C. Field observations of the antimalarial piperaquine. Chinese Med. J. 95 (1982) 281-286
7. Davis T.M., Hung T.Y., Sim I.K., Karunajeewa H.A., and Ilett K.F. Piperaquine: a resurgent antimalarial drug. Drugs 65 (2005) 75-87
8. Denis M.B., Davis T.M., Hewitt S., Incardona S., Nimol K., Fandeur T., Poravuth Y., Lim C., and Socheat D. Efficacy and safety of dihydroartemisinin-piperaquine (Artekin) in Cambodian children and adults with uncomplicated falciparum malaria. Clin. Infect. Dis. 35 (2002) 1469-1476
9. Giao P.T., de Vries P.J., Hung L.Q., Binh T.Q., Nam N.V., and Kager P.A. CV8, a new combination of dihydroartemisinin, piperaquine, trimethoprim and primaquine, compared with atovaquone-proguanil against falciparum malaria in Vietnam. Trop. Med. Int. Health 9 (2004) 209-216
10. Hien T.T. An overview of the clinical use of artemisinin and its derivatives in the treatment of falciparum malaria in Viet Nam. Trans. R. Soc. Trop. Med. Hyg. 88 (1994) S7-S8
11. Hien T.T., and White N.J. Qinghaosu. Lancet 341 (1993) 603-608
12. Hien T.T., Dolecek C., Pham P.M., Nguyen T.D., Nguyen T.T., Le H.T., Dong T.H., Tran T.T., Stepniewska K., White N.J., and Farrar J. Dihydroartemisinin-piperaquine against multidrug-resistant Plasmodium falciparum malaria in Vietnam: randomised clinical trial. Lancet 363 (2004) 18-22
13. Hung T.Y., Davis T.M., Ilett K.F., Karunajeewa H., Hewitt S., Denis M.B., Lim C., and Socheat D. Population pharmacokinetics of piperaquine in adults and children with uncomplicated falciparum or vivax malaria. Br. J. Clin. Pharmacol. 57 (2004) 253-262
14. ®) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children. Trans. R. Soc. Trop. Med. Hyg. 100 (2006) 1105-1111
15. Karunajeewa H., Lim C., Hung T.Y., Ilett K.F., Denis M.B., Socheat D., and Davis T.M. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria. Br. J. Clin. Pharmacol. 57 (2004) 93-99
16. Mayxay M., Thongpraseuth V., Khanthavong M., Lindegardh N., Barends M., Keola S., Pongvongsa T., Phompida S., Phetsouvanh R., Stepniewska K., White N.J., and Newton P.N. An open, randomized comparison of artesunate plus mefloquine vs. dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria in the Lao People's Democratic Republic (Laos). Trop. Med. Int. Health 11 (2006) 1157-1165
17. McGready R., Cho T., Keo N.K., Villegas L., Looareesuwan S., White N.J., and Nosten F. Artemisinin antimalarials in pregnancy: a prospective treatment study of 539 multidrug resistant Plasmodium falciparum episodes. Clin. Infect. Dis. 33 (2001) 2009-2011
18. McIntosh, H.M., Olliaro, P., 2000. Artemisinin derivatives for treating uncomplicated malaria. Cochrane. Database. Syst. Rev. 2, CD000256.
19. Muheki C., McIntyre D., and Barnes K.I. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop. Med. Int. Health 9 (2004) 959-966
20. Nosten F., Luxemburger C., ter Kuile F.O., Woodrow C., Eh J.P., Chongsuphajaisiddhi T., and White N.J. Treatment of multidrug-resistant Plasmodium falciparum malaria with 3-day artesunate-mefloquine combination. J. Infect. Dis. 170 (1994) 971-977
21. Nosten F., van Vugt M., Price R., Luxemburger C., Thway K.L., Brockman A., McGready R., ter Kuile F., Looareesuwan S., and White N.J. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356 (2000) 297-302
22. Price R.N., Nosten F., Luxemburger C., ter Kuile F., Paiphun L., Chongsuphajaisiddhi T., and White N.J. The effects of artemisinin derivatives on malaria transmissability. Lancet 347 (1996) 1654-1658
23. Raynes K. Bisquinoline antimalarials: their role in malaria chemotherapy. Int. J. Parasitol. 29 (1999) 367-379
24. Smithuis F., Kyaw M.K., Phe O., Aye K.Z., Htet L., Barends M., Lindegardh N., Singtoroj T., Ashley E.A., Lwin S., Stepniewska K., and White N.J. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison. Lancet 367 (2006) 2075-2085
25. Stepniewska K., and White N.J. Some considerations in the design and interpretation of antimalarial drug trials in uncomplicated falciparum malaria. Malaria J. 5 (2006) 127
26. Tangpukdee N., Krudsood S., Thanachartwet W., Chalermrut K., Pengruksa C., Srivilairit S., Silachamroon U., Wilairatana P., Phongtananant S., Kano S., and Looareesuwan S. An open randomized clinical trial of Artekin vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria. Southeast. Asian. J. Trop. Med. Public. Health 36 (2005) 1085-1091
27. Tarning J., Lindegardh N., Annerberg A., Singtoroj T., Day N.P., Ashton M., and White N.J. Pitfalls in estimating piperaquine elimination. Antimicrob. Agents. Chemother. 49 (2005) 5127-5128
28. ter Kuile F.O., Nosten F., Luxemburger C., Kyle D., Teja-Isavadharm P., Phaipun L., Price R.N., Chongsuphajaisiddhi T., and White N.J. Mefloquine treatment of acute falciparum malaria: A prospective study of non-serious adverse effects in 3673 patients. Bull. World Health Organ. 73 (1995) 631-642
29. Touze J.E., Heno P., Fourcade L., Deharo J.C., Thomas G., Bohan S., Paule P., Riviere P., Kouassi E., and Buguet A. The effects of antimalarial drug on ventricular repolarization. Am. J. Trop. Med. Hyg. 67 (2002) 54-60
30. van Vugt M., Wilairatana P., Gemperli B., Gathmann I., Phaipun L., Brockman A., Luxemburger C., White N.J., Nosten F., and Looareesuwan S. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. Am. J. Trop. Med. Hyg. 60 (1999) 936-942
31. Vennerstrom J.L., Ellis W.Y., Ager A.L., Andersen S.L., Gerena L., and Milhous W.K. Bisquinolines.1.N,N-bis (7-chloroquinolin-4-yl) alkanediamines with potential against chloroquine resistant malaria. J. Med. Chem. 35 (1992) 2129-2134
32. White N.J. Antimalarial drug resistance and combination therapy. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 354 (1999) 739-749
33. White N.J., van Vugt M., and Ezzet F. Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine. Clin. Pharmacokinet. 37 (1999) 105-125
34. WHO, 2001. Roll Back Malaria Technical Consultation. Antimalarial drug combination therapy. World Health Organization, Geneva, WHO/CDS/RBM/2001.35.
35. WHO, 2003. Assessment of the safety of artemisinin compounds in pregnancy. World Health Organization, Geneva.
36. WHO, 2006. Guidelines for the Treatment of Malaria. World Health Organization, Geneva. http://www.who.int/malaria/treatmentguidelines.html [accessed 28 March 2007].
37. Wilairatana P., Krudsood S., Chalermrut K., Pengruksa C., Srivilairit S., Silachamroon U., Treeprasertsuk S., and Looareesuwan S. An open randomized clinical trial of Artecom vs artesunate-mefloquine in the treatment of acute uncomplicated falciparum malaria in Thailand. Southeast Asian J. Trop. Med. Public. Health 33 (2002) 519-524
38. Ying X., Feng-Zhen O., and Pei-Quan C. Randomized trial of Artekin and Artekin (T) for treatment of uncomplicated falciparum malaria patients. China Trop. Med. 3 (2003) 723-725